{
    "organizations": [],
    "uuid": "f57d39c38cc2e67b512fd6bede2461f342039b21",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/02/02/globe-newswire-cambrex-to-announce-fourth-quarter-and-full-year-2017-financial-results-on-february-8-2018.html",
    "ord_in_thread": 0,
    "title": "Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "EAST RUTHERFORD, N,J., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that fourth quarter and full year 2017 financial results will be released on Thursday, February 8, 2018 before the market opens.\nThe Company will host a conference call to discuss the financial results.\nFourth Quarter 2017 Earnings Conference Call When: Thursday, February 8, 2018 at 8:30 a.m. Eastern Time Dial-in: 1-888-394-8218 for U.S. 1-323-701-0226 for International Passcode: 9709552 Dial-in Replay: 1-888-203-1112 for U.S. 1-719-457-0820 for International Passcode: 9709552 Available through Thursday, February 15, 2018 Webcast: www.cambrex.com About Cambrex\nCambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. For more information, please visit www.cambrex.com .\nContact:\nStephanie LaFiura\nInvestor Relations Associate\nTel: 201-804-3037\nEmail: stephanie.lafiura@cambrex.com\nSource:Cambrex Corporation",
    "published": "2018-02-02T17:15:00.000+02:00",
    "crawled": "2018-02-02T20:44:25.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "east",
        "rutherford",
        "n",
        "globe",
        "newswire",
        "cambrex",
        "corporation",
        "nyse",
        "cbm",
        "leading",
        "manufacturer",
        "small",
        "molecule",
        "innovator",
        "generic",
        "active",
        "pharmaceutical",
        "ingredient",
        "apis",
        "today",
        "announced",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "released",
        "thursday",
        "february",
        "market",
        "open",
        "company",
        "host",
        "conference",
        "call",
        "discus",
        "financial",
        "result",
        "fourth",
        "quarter",
        "earnings",
        "conference",
        "call",
        "thursday",
        "february",
        "eastern",
        "time",
        "international",
        "passcode",
        "replay",
        "international",
        "passcode",
        "available",
        "thursday",
        "february",
        "webcast",
        "cambrex",
        "cambrex",
        "corporation",
        "innovative",
        "life",
        "science",
        "company",
        "provides",
        "product",
        "service",
        "technology",
        "accelerate",
        "development",
        "commercialization",
        "small",
        "molecule",
        "therapeutic",
        "company",
        "offer",
        "active",
        "pharmaceutical",
        "ingredient",
        "apis",
        "advanced",
        "intermediate",
        "enhanced",
        "drug",
        "delivery",
        "product",
        "branded",
        "generic",
        "pharmaceutical",
        "development",
        "manufacturing",
        "capability",
        "include",
        "enzymatic",
        "biotransformations",
        "high",
        "potency",
        "apis",
        "high",
        "energy",
        "chemical",
        "synthesis",
        "controlled",
        "substance",
        "information",
        "please",
        "visit",
        "contact",
        "stephanie",
        "lafiura",
        "investor",
        "relation",
        "associate",
        "tel",
        "email",
        "source",
        "cambrex",
        "corporation"
    ]
}